Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKitwave Regulatory News (KITW)

  • This share is currently suspended. It was suspended at a price of 294.00
  • There is currently no data for KITW

Form 8.3 KITWAVE GROUP PLC

10 Mar 2026 13:31

RNS Number : 0895W
Barclays PLC
10 March 2026
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

KITWAVE GROUP PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

09 Mar 2026

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

1p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

753,723

0.90%

397,705

0.47%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

397,705

0.47%

752,903

0.90%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

1,151,428

1.38%

1,150,608

1.37%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

1p ordinary

Purchase

13,873

2.9400 GBP

1p ordinary

Purchase

10,050

2.9407 GBP

1p ordinary

Purchase

7,549

2.9451 GBP

1p ordinary

Purchase

4,698

2.9500 GBP

1p ordinary

Purchase

1,532

2.9486 GBP

1p ordinary

Purchase

980

2.9499 GBP

1p ordinary

Sale

12,574

2.9400 GBP

1p ordinary

Sale

12,337

2.9399 GBP

1p ordinary

Sale

9,086

2.9469 GBP

1p ordinary

Sale

8,814

2.9500 GBP

1p ordinary

Sale

4,600

2.9397 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

1p ordinary

SWAP

Increasing Long

4,600

2.9397 GBP

1p ordinary

SWAP

Increasing Long

12,337

2.9399 GBP

1p ordinary

SWAP

Increasing Long

5,342

2.9400 GBP

1p ordinary

SWAP

Decreasing Long

10,821

2.9400 GBP

1p ordinary

SWAP

Decreasing Long

196

2.9401 GBP

1p ordinary

SWAP

Decreasing Long

7,549

2.9451 GBP

1p ordinary

CFD

Decreasing Short

5,016

2.9405 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercise

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

10 Mar 2026

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETGPUQGWUPQGWU
Date   Source Headline
16th Oct 20257:00 amRNSHolding(s) in Company
11th Aug 20257:00 amRNSChange of Accounting Reference Date
18th Jul 202512:03 pmRNSHolding(s) in Company
11th Jul 20254:19 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSInterim Results
10th Jun 20257:00 amRNSNotice of Results
2nd Jun 20257:00 amRNSAppointment of Non-Executive Chair
7th May 20257:00 amRNSTrading Update
9th Apr 20257:00 amRNSDirector/PDMR Shareholdings
28th Mar 202512:13 pmRNSResult of AGM
12th Mar 20257:00 amRNSExercise of Warrants and Total Voting Rights
11th Mar 20252:30 pmRNSDirector/PDMR Shareholding
10th Mar 20257:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSDividend Timetable
5th Mar 20257:00 amRNSNotice of AGM and Publication of Annual Report
4th Mar 20257:30 amRNSManagement Incentive Plan Options Exercised
4th Mar 20257:00 amRNSFinal Results
19th Feb 20259:10 amRNSHolding(s) in Company
18th Feb 20257:00 amRNS-RInvestor Webinar
12th Feb 20257:00 amRNSNotice of Results
7th Nov 20247:00 amRNSTrading Update
11th Oct 202410:30 amRNSDirector/PDMR Shareholding
3rd Oct 20245:00 pmRNSPre-Emption Group Reporting
30th Sep 20245:53 pmRNSHolding(s) in Company
30th Sep 20244:47 pmRNSHolding(s) in Company
30th Sep 20244:42 pmRNSHolding(s) in Company
30th Sep 20244:19 pmRNSHolding(s) in Company
27th Sep 20243:32 pmRNSCompletion of Acquisition
26th Sep 20242:06 pmRNSHolding(s) in Company
25th Sep 20247:00 amRNSResult of Capital Raising
5th Sep 202412:28 pmRNSHolding(s) in Company
3rd Sep 20247:00 amRNSTrading Update
8th Aug 20244:16 pmRNSHolding(s) in Company
8th Jul 20247:00 amRNSHolding(s) in Company
2nd Jul 20242:45 pmRNSDirector/PDMR Shareholding
2nd Jul 20247:00 amRNSInterim Results
25th Jun 20247:00 amRNSHolding(s) in Company
11th Jun 20247:00 amRNSNotice of Results
8th May 20247:00 amRNSHolding(s) in Company
2nd May 20247:00 amRNSTrading Update
17th Apr 20242:51 pmRNSDirector/PDMR Shareholding
3rd Apr 202412:04 pmRNSDirector/PDMR Shareholdings
2nd Apr 20243:01 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSAcquisition of Total Foodservice Solutions Limited
22nd Mar 20241:14 pmRNSResult of AGM and Directorate Change
22nd Mar 202410:16 amRNSHolding(s) in Company
4th Mar 20247:00 amRNSDividend Timetable
1st Mar 20243:42 pmRNSReplacement: Exercise of Warrants & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.